C12Y 204/01146
Beta-1,3-galactosyl-o-glycosyl-glycoprotein beta-1,3-n-acetylglucosaminyltransferase
Official title: Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (2.4.1.146)
C12Y204/01146 (Beta-1,3-galactosyl-o-glycosyl-glycoprotein beta-1,3-n-acetylglucosaminyltransferase) appears on 8 US grants and 13 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 13
- Assignees
- 11
- Inventors
- 33
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 2 | 6 |
| 2025 | 2 | 0 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified beta-1,3-n-acetylglucosaminyltransferase polypeptides14 Jul 2026US 12,680,086 B2Amyris, Inc.
- Production of human milk oligosaccharides in microbial hosts with engineered import/export5 May 2026US 12,618,091 B2Chr. Hansen A/S
- Identification of an α-1,2-fucosyltransferase for the in vivo production of pure LNFP-I16 Sep 2025US 12,416,030 B2Dsm IP Assets B.V.
- Production of human milk oligosaccharides in microbial hosts with engineered import / export9 Sep 2025US 12,410,454 B2Chr. Hansen A/S
- Construction method and application of microorganism capable of realizing high production of lacto-N-neotetraose24 Sep 2024US 12,098,402 B2Jiangnan University
- Compositions and methods relating to age-related, neurological, and vascular disease conditions20 Aug 2026US 2026/0241037 A1The Board of Trustees of the Leland Stanford Junior University
- Identification of an alpha-1,2-fucosyltransferase for the in vivo production of pure lnfp-i19 Dec 2024US 2024/0417766 A1Dsm IP Assets B.V.
- Cellular production of di- and/or oligosaccharides7 Nov 2024US 2024/0368651 A1Inbiose N.V.
- Production of Human Milk Oligosaccharides in Microbial Hosts with Engineered Import/Export26 Sep 2024US 2024/0318216 A1Chr. Hansen HMO GmbH
- Extracellular production of glycosylated products5 Sep 2024US 2024/0294958 A1Inbiose N.V.
Most cited
By later US patents